This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Chen, C. et al. A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal. Sci. Adv. 8, eabo4363 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Phillips, R. Novel JAK3-specific inhibitor safe and effective in mouse RA model. Nat Rev Rheumatol 18, 551 (2022). https://doi.org/10.1038/s41584-022-00839-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-022-00839-8